French Retail REITs Stock News

Key Insights Using the 2 Stage Free Cash Flow to Equity, MEMSCAP fair value estimate is €5.61 With €4.50 share price...

Edenred (ENXTPA:EDEN) is quietly tightening its grip on Europe’s electric trucking transition, teaming up with Daimler Truck to power the new TruckCharge Network and expand access via its UTA Edenred and Spirii platforms. See our latest analysis for Edenred. Against that backdrop, Edenred’s 30 day share price return of 1.95% offers only a modest pause in what has been a much tougher spell. The year to date share price return is down 39.71 percent and the five year total shareholder return has...

If you are wondering whether Nexans at €124.40 is still a smart buy after its strong run, or if most of the upside is already priced in, this piece will walk you through the key valuation angles to help you decide. The stock has dipped 1.0% over the last week, but that comes after a solid 4.0% gain over the past month, a 19.3% rise year to date and a 22.8% jump over the last year, building on a 55.7% 3-year and 129.8% 5-year performance. Those moves have been underpinned by Nexans’ strategic...

Schneider Electric (ENXTPA:SU) has been quietly grinding higher over the past month, adding about 6% even after a softer past week. That mix of short term noise and steady gains makes the current setup interesting. See our latest analysis for Schneider Electric. That recent 6.4% 1 month share price return sits against a slightly negative year to date move, while a modest 1 year total shareholder return of 0.7% caps a far stronger 3 year total shareholder return above 90%. This suggests...

Alstom (ENXTPA:ALO) has quietly outperformed the broader market over the past quarter, with the stock up roughly 11% in the past month and 15% over the past 3 months. See our latest analysis for Alstom. Zooming out, that 10.59% 1 month share price return builds on a solid year to date gain. A 1 year total shareholder return of 13.83% suggests sentiment is steadily improving despite a still weak 5 year total shareholder return. If Alstom’s recent momentum has caught your attention, it could be...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

There wouldn't be many who think Largo SA's ( EPA:ALLGO ) price-to-sales (or "P/S") ratio of 0.2x is worth a mention...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Invibes Advertising N.V. ( EPA:ALINV ) shareholders would be excited to see that the share price has had a great month...

Key Insights Significant control over Neurones by private companies implies that the general public has more power to...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

ENENSYS Technologies SA ( EPA:ALNN6 ) shareholders would be excited to see that the share price has had a great month...

Safran recently saw a 300%+ jump in trading volume as investors reacted to its positioning in a recovering aerospace and defense market and looked ahead to its February 2026 earnings announcement. This surge in activity highlights how expectations around Safran’s focus on aircraft interiors, avionics and propulsion systems are shaping investor interest in the sector. We’ll now examine how this renewed trading interest, tied to Safran’s aerospace rebound exposure, interacts with and...

Sanofi (ENXTPA:SAN) shares have quietly bounced about 2% over the past week, even though they are still down for the year, drawing attention from investors looking for more resilient pharma exposure. See our latest analysis for Sanofi. That recent 7 day share price return of 2.21 percent only slightly offsets a year to date share price decline of 12.66 percent. This suggests sentiment is stabilising rather than surging, despite steady earnings growth and pipeline progress. If Sanofi has you...

Kering (ENXTPA:KER) has quietly climbed this year, and with the share price hovering around €303 after a recent pullback, investors are starting to reassess whether the luxury group’s recovery has more room to run. See our latest analysis for Kering. The recent pullback sits against a strong backdrop, with a roughly 28 percent year to date share price return. This suggests sentiment toward Kering’s turnaround is improving even as the three and five year total shareholder returns remain deeply...

Nexans S.A. ( EPA:NEX ), might not be a large cap stock, but it received a lot of attention from a substantial price...

Key Insights Given the large stake in the stock by institutions, Alten's stock price might be vulnerable to their...

Veolia Environnement SA ( EPA:VIE ) saw its share price hover around a small range of €28.40 to €29.97 over the last...

If you are wondering whether Sanofi is quietly turning into a bargain while everyone is focused on flashier names, this deep dive will help you assess whether the current price reflects its long term potential. Despite a solid 5 year gain of 28.1%, the stock is down 12.7% year to date and 4.6% over the last month, suggesting that sentiment has cooled even as the long term story remains intact. Recently, markets have been reacting to Sanofi's strategic shifts in its pharmaceutical pipeline...

If you are wondering whether LVMH Moët Hennessy Louis Vuitton Société Européenne is still a quality luxury name at a fair price, you are not alone. That is exactly what we are going to unpack here. The share price has been relatively steady but slightly positive, up around 1.2% over the last week and 3.6% over the past month, while sitting roughly flat year to date and modestly higher over 1 year. This hints at cautious optimism rather than a runaway rally. Recent headlines have focused on...

Wondering if Publicis Groupe is quietly turning into a value opportunity, or if the market has already priced in the upside? The stock has edged up about 1.5% over the last week and 5.5% over the past month, even though it is still down roughly 13.9% year to date and 10.2% over the last year after a very strong 3 and 5 year run. Recent headlines have focused on Publicis tightening its focus on high margin data and tech led services and securing new global client mandates, reinforcing its...

In July 2025, Laura Burdese took over as CEO of Bulgari, succeeding long-time leader Jean-Christophe Babin, who remains chairman and head of the Bulgari Hotel business unit. This leadership reshuffle at one of LVMH’s key jewelry and hospitality brands could subtly reshape how the group balances heritage with expansion. We’ll now explore how Burdese’s appointment at Bulgari might influence LVMH’s broader investment narrative, especially around brand diversification and luxury hospitality. The...

If you are wondering whether Atos at around €46 is a turnaround bargain or a value trap, you are not the only one. That is exactly what this breakdown is going to tackle. The stock has swung hard lately, down 15.9% over the last week but still up 6.0% over 30 days, with an eye catching 85.8% gain year to date and a 121.2% rise over the past year after a brutal multi year slide. Those moves come after years of restructuring and strategic shifts that have investors rethinking the long term...

Sanofi halted development of tolebrutinib in primary progressive multiple sclerosis after the drug missed its Phase 3 primary endpoint. The company signed a licensing deal worth up to $1.04 billion with ADEL for an investigational Alzheimer’s antibody. Sanofi expanded its collaboration with Dren Bio to advance next generation B cell targeted therapies for autoimmune diseases. Regulatory progress includes approvals for new rare disease medicines in China and EMA orphan designation for an...